Diabetes diagnosis based on glucose control levels and time until diagnosis: a regression discontinuity approach to assess the effect on direct healthcare costs

Table 3 Descriptive statistics on healthcare use and costs for those treated (HbA1c ≥ 6.5%) vs controls (HbA1c < 6.5%). Span = 24 months

	Average glucose control (HbA1c) < 6.5% N = 27,079		Average glucose control (HbA1c) ≥ 6.5% N = 20,440
	Mean	Median	Mean	Median
Number of medical visits	43.87	35.00	43.99	35.00
Cost of medical visits	2,815.28	1,816.86	2,820.69	1,822.56
Cost of procedures	3,745.23	0.00	4,001.21**	0.00
Drugs cost	775.22	0.00	812.31	0.00
Total costs during the first 6 months after the laboratory test	7,335.73	1,918.02	7,634.21	1,919.12
Accumulated costs during the 6 months before the laboratory test^a	1,016.23 (7,340.44)		805.76*** (5,898.62)

^a Mean and standard deviation within brackets
The stars represent the tests for statistical differences between means, which denote: *: p-value < 0.10; **: p-value < 0.05; ***: p-value < 0.01

ISSN: 2191-1991